278 related articles for article (PubMed ID: 30674321)
1. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
Serra W; Marziliano N
Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
[TBL] [Abstract][Full Text] [Related]
2. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
[TBL] [Abstract][Full Text] [Related]
3. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
Putko BN; Wen K; Thompson RB; Mullen J; Shanks M; Yogasundaram H; Sergi C; Oudit GY
Heart Fail Rev; 2015 Mar; 20(2):179-91. PubMed ID: 25030479
[TBL] [Abstract][Full Text] [Related]
4. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
5. Myocardial lipid content in Fabry disease: a combined
Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
[TBL] [Abstract][Full Text] [Related]
6. Anderson-Fabry disease management: role of the cardiologist.
Pieroni M; Namdar M; Olivotto I; Desnick RJ
Eur Heart J; 2024 Apr; 45(16):1395-1409. PubMed ID: 38486361
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiogram and Imaging: An Integrated Approach to Arrhythmogenic Cardiomyopathies.
Savino K; Bagliani G; Crusco F; Padeletti M; Lombardi M
Card Electrophysiol Clin; 2018 Jun; 10(2):413-429. PubMed ID: 29784492
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.
Deva DP; Hanneman K; Li Q; Ng MY; Wasim S; Morel C; Iwanochko RM; Thavendiranathan P; Crean AM
J Cardiovasc Magn Reson; 2016 Mar; 18():14. PubMed ID: 27036375
[TBL] [Abstract][Full Text] [Related]
9. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
[TBL] [Abstract][Full Text] [Related]
10. Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.
Walter TC; Knobloch G; Canaan-Kuehl S; Greiser A; Sandek A; Blaschke D; Denecke T; Hamm B; Makowski MR
Acta Radiol; 2017 Aug; 58(8):914-921. PubMed ID: 27799574
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.
Faro DC; Losi V; Rodolico MS; Torrisi EM; Colomba P; Duro G; Monte IP
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761944
[TBL] [Abstract][Full Text] [Related]
12. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
[TBL] [Abstract][Full Text] [Related]
13. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.
Perry R; Shah R; Saiedi M; Patil S; Ganesan A; Linhart A; Selvanayagam JB
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1230-1242. PubMed ID: 31272606
[TBL] [Abstract][Full Text] [Related]
15. Arrhythmia and Clinical Cardiac Findings in Children With Anderson-Fabry Disease.
Wilson HC; Hopkin RJ; Madueme PC; Czosek RJ; Bailey LA; Taylor MD; Jefferies JL
Am J Cardiol; 2017 Jul; 120(2):251-255. PubMed ID: 28550929
[TBL] [Abstract][Full Text] [Related]
16. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal.
Del Franco A; Iannaccone G; Meucci MC; Lillo R; Cappelli F; Zocchi C; Pieroni M; Graziani F; Olivotto I
Heart Fail Rev; 2024 Mar; 29(2):431-444. PubMed ID: 38006470
[TBL] [Abstract][Full Text] [Related]
17. Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?
Acampa W; D'Antonio A; Imbriaco M; Pisani A; Cuocolo A
J Nucl Cardiol; 2022 Jun; 29(3):1439-1445. PubMed ID: 32378117
[TBL] [Abstract][Full Text] [Related]
18. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
19. Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.
Ávila-Sánchez DA; Cambronero-Cortinas E; Barreiro-Pérez M; Rodríguez-Hernández JL; Díaz-Fernández B; Sánchez PL
Am J Case Rep; 2020 Oct; 21():e925631. PubMed ID: 33119553
[TBL] [Abstract][Full Text] [Related]
20. Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia.
Poulin MF; Shah A; Trohman RG; Madias C
World J Clin Cases; 2015 Jun; 3(6):519-24. PubMed ID: 26090373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
